Chapel Hill public company could be looking for a buyer soon


Short on cash and facing a potential delisting, a Chapel Hill medical technology company could look toward a sale or merger.

Previous Rockville's RegenxBio lays out potential path to market for its first gene therapy treatments
Next Froedtert Health posts loss of $43.5M in latest quarter